Sensus Healthcare (NASDAQ:SRTS – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.20), Zacks reports. The company had revenue of $8.34 million for the quarter, compared to analyst estimates of $7.23 million. Sensus Healthcare had a net margin of 15.90% and a return on equity of 12.60%.
Sensus Healthcare Stock Down 3.3%
SRTS opened at $4.66 on Friday. The stock has a market cap of $76.87 million, a P/E ratio of 11.65 and a beta of 1.30. Sensus Healthcare has a 12 month low of $4.01 and a 12 month high of $9.33. The company has a fifty day simple moving average of $4.61 and a 200 day simple moving average of $6.14.
Wall Street Analyst Weigh In
SRTS has been the subject of a number of research analyst reports. Lake Street Capital dropped their target price on shares of Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating for the company in a research note on Tuesday, March 11th. HC Wainwright reiterated a “buy” rating and issued a $12.00 price objective on shares of Sensus Healthcare in a research report on Friday, April 4th.
About Sensus Healthcare
Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
Featured Articles
- Five stocks we like better than Sensus Healthcare
- How Investors Can Find the Best Cheap Dividend Stocks
- CRSPR Stock Could Be Ready to Deliver on Its Massive Promise
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Analysts and Institutions Continue to Bet Big on Alphabet
- ETF Screener: Uses and Step-by-Step Guide
- Walmart Stock Alert: Big Price Move Expected Soon
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
